Moolec Science (MLEC) Other Non-Current Assets (2024)
Moolec Science's (MLEC) quarterly Other Non-Current Assets came in at $190517.0 in Q2 2024.
Moolec Science (MLEC) Other Non-Current Assets (2024) Analysis & Trends
Moolec Science has disclosed Other Non-Current Assets across 1 years of filings, most recently posting $190517.0 for Q2 2024.
- Other Non-Current Assets for Q2 2024 came in at $190517.0, changed N/A year-over-year; the trailing twelve-month figure through Jun 2024 was $190517.0 (changed N/A YoY), and the FY2024 annual result was $190517.0, changed N/A from the prior year.
- Other Non-Current Assets came in at $190517.0 for Q2 2024 at Moolec Science.
- In the past five years, Other Non-Current Assets ranged from a high of $190517.0 in Q2 2024 to a low of $190517.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 190,517.00 |